PETQ News and Press, PetIQ Inc. From 08/13/22

PetIQ, Inc. (PETQ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 P.M. ET Company Participants Katie Turner - Investor Relations Cord Christensen - Chairman and Chief Executive Officer Zvi Glasman - Chief Financial Officer Michael Smith - President and ...

Gainers: OraSure Technologies ( OSUR ) +28% . BioAtla ( BCAB ) +24% . Catalyst Pharmaceuticals ( CPRX ) +16% . Clovis Oncology ( CLVS ) +13% . Quanterix ( QTRX ) +13% . Losers: Singular Genomics Systems ( OMIC ...

PetIQ press release ( NASDAQ: PETQ ): Q2 GAAP EPS of $0.16 misses by $0.18 . Revenue of $252M (-7.0% Y/Y) misses by $7.4M . Q3 Outlook : Net sales: $200M to $210M vs. consensus of $234.32M; Adjusted EBITDA: $16.5M to $17.5M. FY2022 Outlook : Net sal...

Second Quarter 2022 Net Income Increased 16.0% to $4.7 Million Reports Adjusted EBITDA of Approximately $28 Million Provides Third Quarter 2022 Guidance and Updates 2022 Annual Outlook EAGLE, Idaho, Aug. 09, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ”...

PetIQ ( NASDAQ: PETQ ) is scheduled to announce Q2 earnings results on Tuesday, August 9th, after market close. The consensus EPS Estimate is $0.34 and the consensus Revenue Estimate is $259.4M (-4.3% Y/Y). Over the last 1 year, PETQ has beaten EPS estimates 25% of...

EAGLE, Idaho, July 19, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the second quarter ended June 30, 2022, on Tuesday, August 9...

EAGLE, Idaho, May 23, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that members of the management team will present at the William Blair 42 nd Annual Growth Stoc...

EAGLE, Idaho, May 18, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of accomplished retail operations executive, John Pearson, to Senior Vice Presiden...

Gainers: Inotiv (NOTV) +41%. TScan Therapeutics (TCRX) +23%. SomaLogic (SLGC) +19%. Veru (VERU) +18%. Celularity (CELU) +17%. Losers: Opiant Pharmaceuticals (OPNT) -16%. Renovacor (RCOR) -15%. Embecta (EMBC) -7%. Wave Life Sciences (WVE) -5%. ...

The following slide deck was published by PetIQ, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: PetIQ, Inc. 2022 Q1 - Results - Earnings Call Presentation